Upload
muriel-potter
View
213
Download
0
Tags:
Embed Size (px)
Citation preview
The road to financiallly sustainable health care in an aging society?
March 2012
Marc Koopmanschap (Claudine de Meijer/Johan Polder/ Bram Wouterse)
Outline
• Overview determinants of HCE• Explanation HCE 1995-2009• Determinants of LTC expenditures• Decomposition of acute care expenditures
• Impact of determinants on HCE• The role of aging in perspective
Health Status
Incidence/prevalence diseaseMortality (TTD)
Disability
ADL, IADL, mobility
Medical consumption
Acute care
Long term care
Informal care
Health care costs (acute care /LTC)
Informal care costs
Medical technology Consumer preferences, income
Health behavior, living and working conditions
Health care systemOrganisation of supply
and insurance, Financial incentives
Wages prices
DemographyAge, sex, Household composition
Informal care supply
Public health policy
Socio-economic status
Model Anderson and Newman (2005)
Determinants Individual level Societal level
Predisposing Age
Gender
Household composition
(Socio-economic status)
Enabling Informal care supply
Individual income
Consumer preferences
National income
Illness/need Health (incl. mortality)
Disability
Societal Medical technology
Wages/prices
Organisation health care
Fact: HCE and Age
0
5000
10000
15000
20000
10 30 50 70 90Age (years)
Men
Women
Fact: (Yearly) HCE at End of Life
0
5000
10000
15000
20000
25000
0102030405060
Time to death in months
Men
Women
Results 1995-2009 on aging and costs (1)• Naive projections of ageing, not taking into account
time to death overestimate cost of aging in acute care by 10-20%.
(as most extra elderly will not be in their expensive last year(s) of life)
• Consensus: time to death important in acute care sector, calender age per se is not!
• However, is time to death really an explanatory variable or more a proxy for health/disability?
LTC determinants of consumption
• Disability – but not general health – main determinant of LTC use (age has a small impact)
• iADL disabilities had a greater effect on homecare, ADL disabilities more on institutional LTC
• The number of disabilities matters, but first disability has a larger effect on use than any additional disability
Probability of LTC use as a function of disability
Aging & LTC expenditures
Old age coincides with more disability and a higher probability to live alone.
After controlling for disability and co-residence status, age hardly influences the level of LTC expenditures.
The effect of age on LTC expenditures
De Meijer, Koopmanschap, Bago d’ Uva, Van Doorslaer (2011)
Co-residence status and LTC spending
The effect of co-residence status
Co-residence status approximates informal care availability.
Informal care substitutes and postpones the use of formal LTC
LTC expenditure determinants
The effect of TTD when controlling for additional covariates
Homecare (population model) Homecare (ext. homecare model)
LTC projections – various scenario’s
Scenario Index per capita LTC expenditures (55+)
in 2040 (2004=100)
“Naïve” (age only) 150 (institutional care = 154; home care =
141)
Age plus trend in co-residence
status
153
“proximity-to-death” (constant
proximity-to-death of disability)
128 (institutional LTC = 129; home care =
124)
Extrapolated recent decrease
in severe disability
117 (homecare)
De Meijer, Koopmanschap, Bago d’ Uva, Van Doorslaer (2011)
Living Longer in Good Health?
Life expectancy by disability status
17,8 18,0 19,1 20,216,1 16,1 15,9 15,7
5,2 5,35,7
6,1
0
8,9 9,1 10,3 11,5
2,0 2,02,0
2,0 3,6 3,63,5
3,4
0,0
5,0
10,0
15,0
20,0
25,0
30,0
35,0
2008 2010 2020 2030 2008 2010 2020 2030
Males Females
Life
exp
ecta
ncy
at a
ge 5
5
LE with severe disability
LE with mild disability
DFLE
Forecast of lifetime LTC spending
Forecast LTC spending (2008-2030)
Individual life proximity spending on LTC
• Future longevity gains coinciding with a compression of severe disability are not very costly per person.
Aggregate population spending on LTC
• Accounts for growing number of elderly
• Increase 56.0% in 2008-2030, from €10.7 to €16.8 bln
Acute care: decomposition HCE growth the Netherlands
• Decomposition of spending on total acute care and separate analyses for hospital care and pharmaceuticals
• Analysis of changes in full marginal expenditure distribution relevant as HCE are heavily skewed
• 1998-2004: real spending growth of 28%, but not uniform across the spending distribution
Acute care spending growth (1998-2004)
-.5
0.5
1C
han
ge in
log
exp
end
iture
0 .2 .4 .6 .8 1Quantile
Full distribution
0.2
.4.6
Ch
ange
in lo
g e
xpe
nditu
re0 .2 .4 .6 .8 1
Quantile
Positive expenditures
Total acute care Hospital and other secondary acute care Pharmaceuticals
Decomposition of growth (1998-2004)
Hospital care• Growth concentrated at centre distribution• Increased admission rates due to relaxation of hospital budgets• Decrease LOS and shift towards more day care and policlinic
care constraint spending at higher quantiles
Pharmaceuticals• Growth concentrated at top of distribution• More intensive/expensive drug use • Technological progress dominates growth, especially at higher
percentiles (monopolistic prices new drugs)• Moderate contribution of shift towards less intensive hospital
treatment (substitution to outpatient drugs)
Overview results of determinants of health care expenditures
Predisposing determinants
Age and gender• age composition of population has a limited (< 1% growth py)
role in growth HCE. • For LTC expenditures, age has some impact, might be proxy for
frailty not measured by disability/health;• Elderly females depend more on LTC services than males; a
longer life expectancy (but less in good health) -> need more formal LTC and have less informal care.
Household composition• Singles are substantially more likely to use LTC, and their
expenditures are much higher (less informal care).
Illness/need determinants
Health and disability
Acute care:
• Time to Death (TTD) important;
• Differences in effect of TTD on disease specific HCE -> TTD vs HCE depends on epidemiology (Wong; de Meijer).
Long term care:
• when controlling for health and esp. disability, effect of both age and TTD is substantially lower
Health status vs disability: dynamics: given disease, less disability -> less LTC costs?? As result of acute care investments?
Enabling determinants
Informal care
• informal care lowers LTC use;
• supply of informal care depends on household composition and (future) female labor participation.
Income
• Macro-income major determinant of HCE;
• In case of comprehensive insurance, individual income limited role in determining HCE.
Consumer preferences
• changing preferences important driver of rising HCE? evidence is scarce; difficult to separate from shifts in health care needs and supply.
Societal determinantsMedical technology• Very important, exact contribution of medical technology hard to
estimate; • The impact of technology on HCE strong for prescription drugs
and hospital care;• medical technology value for money? Very broad range cost-
effectiveness;
Organization of health care• might clearly affect HCE, but evidence on the link between
institutional aspects, ageing and HCE limited.• Cost sharing lowers HCE, managed competition lowered
prices, but HC-utilisation increased considerably
Wages/prices• Baumol effect (for NL estimated as 0.8% p.a.);• serious labour shortages to come, will raise wages.
The role of aging in perspective (1)
• Health care costs related to interplay of:– Demography (age, household composition)– Epidemiology/health/disability– Technology (plus demand attitude)
• Mechanisms different for acute care vs LTC• Self assessed health, chronic conditions, TTD and cause
of death -> acute care costs;
• Disability & household composition -> LTC costs
• Medical technology major role in boosting HCE in acute care, but might limit disability and lower LTC demand;
The role of aging in perspective (2)• Häkkinen (2008): “.. future expenditure is more likely
to be determined by health policy than inevitable trends in demography”.
– Calls for policies that lower disability further..
• Evans et al. (2001): there is nothing fixed or clinically imperative about current age-specific health care spending, nor do countries need to accept as an unalterable fact that age-specific per capita HCE in the future must necessarily go up for all groups, and especially for the elderly.
The role of aging in perspective (3)• From a broader policy perspective: when further
advances in medical technology are allowed to be introduced swiftly (for elderly) and growing expectations of future elderly regarding service levels are accommodated, all researchers expect that HCE as % of GDP will increase considerably, probably together with healthy life expectancy.
– Calls for choices in medical technology….
• Hence, the policy question is: (how much) are we willing to pay for all these “advances” in care?